Listar RESULTADOS DE INVESTIGACIÓN por autor 

Listar RESULTADOS DE INVESTIGACIÓN por autor "Soriano, Vicente"

Mostrando ítems 21-40 de 109

    • Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis 

      Arranz-Herrero, Javier; Presa, Jesús; Rius-Rocabert, Sergio; Utrero-Rico, Alberto; Arranz-Arija, José Ángel; Lalueza, Antonio; Escribese, María M; Ochando, Jordi; Soriano, Vicente; Nistal-Villan, Estanislao (International Journal of Infectious Diseases, 2023)
      Background: The clinical burden of influenza is increasing worldwide. Aging, immunosuppression, and underlying respiratory illness are determinants of poor clinical outcomes, including greater mortality. Bacterial infections ...

    • Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process 

      Marques-Gomes, João; Salt, Matthew J.; Pereira-Neto, Rita; Barteldes, Franca S.; Gouveia-Barros, Vera; Carvalho, Alexandre; d’Arminio-Monforte, Antonella; De-la-Torre-Rosas, Alethse; Harris, Amy; Esteves, Catarina; Maor, Carcom; Mora, Cristina; Oliveira, Carla; Sousa, Cristina; Richman, Douglas D.; Martinez, Esteban; Cota-Medeiros, Fábio; Gramacho, Filipa; Behrens, Georg M. N.; Gonçalves, Graça; Farinha, Helena; Nabais, Isabel; Vaz-Pinto, Inês; Sierra-Madero, Juan; Sousa-Gago, Joaquim; Thornhill, John; Vera, José; Erceg-Tusek, Maja; Tavares, Margarida; Vasconcelos, Miguel; Fernandes, Nuno; Gianotti, Nicola; Langebeek, Nienke; Anjos, Paulo; Couto, Raquel; Fernandes, Ricardo; Rajasuriar, Reena; Serrão, Rosário; Watson, Shaun; Branco, Teresa; Teixeira, Tiago; Soriano, Vicente (John Wiley and Sons Inc, 2022)
      Objectives: HIV outcomes centre primarily around clinical markers with limited focus on patient-reported outcomes. With a global trend towards capturing the outcomes that matter most to patients, there is agreement that ...

    • Envisioning a hepatitis delta cure with new antivirals 

      Soriano, Vicente ; Mendoza, Carmen de; Barreiro, Pablo; Treviño, Ana ; Corral, Octavio Jorge (Future Medicine Ltd., 2021)
      Envisioning a hepatitis delta cure with new antivirals

    • Envisioning hepatitis delta cure without functional hepatitis B cure 

      Soriano, Vicente; de Mendoza, Carmen; Barreiro, Pablo (AIDS reviews, 2022)
      [abstract not available]

    • Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2 

      Tzou, Philip L.; Descamps, Diáne; Rhee, Soo-Yon; Raugi, Dana N; Charpentier, Charlotte; Taveira, Nuno; Smith, Robert A; Soriano, Vicente ; Mendoza, Carmen de; Holmes, Susan; Gottlieb, Geoffrey S.; Shafer, Robert W. (Journal of Infectious Diseases, 06/2020)
      Background: HIV-1 and HIV-2 differ in their antiretroviral (ARV) susceptibilities and drug resistance mutations (DRMs). Methods: We analyzed published HIV-2 pol sequences to identify HIV-2 treatment-selected mutations ...

    • Gene editing for HIV cure at the edge 

      Soriano, Vicente (AIDS Reviews, 01/2019)
      Whereas advances in antiretroviral therapy and its widespread use are providing huge benefits in terms of prventing new HIV transmissions to uninfected individuals as well as halting disease progression in patients, the ...

    • Hepatitis B Gene Therapy Coming to Age 

      Soriano, Vicente (AIDS Reviews, 04/2018)
      The major pandemics caused by chronic viral infections is produced by HIV, hepatitis C virus (HCV), and hepatitis B virus (HBV), with estimates of 38, 70, and 250 million people worldwide, respectively (Fig. 1). During the ...

    • Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies 

      Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; de Mendoza, Carmen; Ramos-Belinchón, Clara; Barreiro, Pablo; Gómez-Gallego, Felix; Corral, Octavio Jorge; Soriano, Vicente (Journal of Viral Hepatitis, 2022)
      Chronic hepatitis C virus (HCV) infection is major cause of decompensated cirrhosis and liver cancer. The advent of curative new antiviral therapies since year 2015 has dramatically improved the prognosis of HCV patients. ...

    • Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach 

      Cachay, Edward R.; Mena, Alvaro; Morano, Luis; Benitez, Laura; Maida, Ivana; Mendoza, Carmen de; Hill, L.; Torriani, F; Soriano, Vicente ; Mathews, Wm. C. (SAGE Publications Inc., 2021)
      Fifty-four consecutive persons with HIV co-infected with hepatitis C virus (HCV) and liver decompensation were treated with direct-acting antivirals (DAA). The HCV treatment was delivered using a multidisciplinary ...

    • Hepatitis Delta Could Be More Frequent than Previously Thought 

      Fernández-Montero, José V.; Soriano, Vicente (AIDS Reviews, 10/2018)
      HDV is a unique defective agent that only infects humans and requires the presence of hepatitis B to complete its life replication cycle within hepatocytes.

    • Hepatitis Delta Estimates in the United States Revisited 

      Soriano, Vicente ; Gómez-Gallego, Felix ; Corral, Octavio Jorge (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 30/10/2019)
      To the Editor—We read with interest the article by Patel and colleagues [1], which reported an unexpected 33% prevalence of anti–hepatitis delta virus antibodies (anti-HDV-Abs) in a large and representative US household ...

    • Hepatitis delta in patients hospitalized in Spain (1997-2018) 

      Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; Ramos-Belinchón, Clara; de Mendoza, Carmen; Aguilera, Antonio; Soriano, Vicente (NLM (Medline), 2021)
      BACKGROUND: Hepatitis delta is the most aggressive form of chronic viral hepatitis. We examined the clinical burden, epidemiological features and time trends for hepatitis delta patients hospitalized in Spain during the ...

    • Hepatitis delta in patients with resolved hepatitis B virus infection 

      Aguilera, Antonio; Rodríguez-Calviño, Javier; Mendoza, Carmen de; Soriano, Vicente (European Journal of Gastroenterology & Hepatology, 09/2018)
      Background The hepatitis delta virus (HDV) causes the most aggressive form of chronic viral hepatitis. As HDV replication requires hepatitis B virus (HBV), HDV screening is limited to HBsAg+ carriers. To date, individuals ...

    • HIV co-infection in HTLV-1 carriers in Spain 

      Mendoza, Carmen de; Caballero, Estrella; Aguilera, Antonio; Benito, Rafael; Maciá, Dolores; García-Costa, Juan; Soriano, Vicente ; Corral, Octavio Jorge ; Gómez-Gallego, Felix ; ...et al.; Morano, Luis (Virus Research, 06/2019)
      Background: Human retroviruses HIV and HTLV share transmission routes. HIV widely spread in Spain during the 80 s through injection drug use and sex, and nowadays HIV rates in Spain account for one of the largest in Europe. ...

    • Hospital admissions in individuals with HTLV-1 infection in Spain 

      Ramos, José M.; Mendoza, Carmen de; Aguilera, Antonio; Barreiro, Pablo; Benito, Rafael; Eirós, José M.; Soriano, Vicente (AIDS, 06/2020)
      OBJECTIVE: To examine the clinical burden and disease spectrum, as well as time trends for human T-cell leukemia virus type 1 (HTLV-1) and HTLV type 2 (HTLV-2) hospital admissions. DESIGN: Retrospective, observational study ...

    • Hot news 

      Fernandez-Montero, José V.; Soriano, Vicente (AIDS Reviews, 2020)
      For the past 5 years, all adults presenting with > 10-fold liver enzyme elevations at the emergency department of the largest hospital in Barcelona were tested for markers of acute viral hepatitis. Out of all positive ...

    • Hot News. A cure for HIV on the horizon 

      Treviño, Ana; Soriano, Vicente (Aids Reviews, 2022)
      [Resumen no disponible]

    • Hot news: Unveiling long COVID-19 disease 

      Soriano, Vicente ; Ganado-Pinilla, Pilar ; Sánchez-Santos, Miguel ; Barreiro, Pablo (AIDS Reviews, 2020)
      The clinical spectrum of “Severe Acute Respiratory Syndrome Coronavirus type 2” (SARS-CoV-2) infection is wider than initially thought. The coronavirus does not establish a chronic cellular infection, in contrast with HIV ...

    • HTLV testing of solid organ transplant donors 

      Mendoza, Carmen de; Roc, Lourdes; Fernández-Alonso, Miriam; Soriano, Vicente (Clinical Transplantation, 2019)
      Carta al editor

    • HTLV-1 infection and health outcomes 

      Ramos, José M.; Mendoza, Carmen de; Soriano, Vicente (The Lancet Infectious Diseases, 04/2020)
      The meta-analysis published by Gill Schierhout and colleagues1 reported an increased relative risk of premature death in individuals infected with HTLV-1 compared with individuals not infected with HTLV-1 (RR 1·57, 95% CI ...